TOPLINE RESULTS FROM THE FIRST RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED, PROSPECTIVE, MULTICENTER STUDY OF DUODENAL MUCOSAL RESURFACING (DMR) EFFICACY, SAFETY, AND IMPACT ON NASH BIOMARKERS IN PATIENTS WITH TYPE 2 DIABETES (T2D)